by Monika Stachura (CERN)
at CERN ( 26-1-022 )
The first bio-medical activity ever performed with the use of the radionuclides produced at ISOLDE is dated to as early as 1979, when a batch of around 70 MBq 167Tm was produced, transported to Dresden , Germany, labelled with citrate and then injected into a patient suffering from a lymphoma cancer. This succesful campaign was then followed by 30 years of extensive research on development of new radiopharmaceuticals for tumor diagnosis and therapy, and develpoment of technogogies for medical isotope production. In the present talk, the pioneer of those activities, Gerd-Jurgen Beyer, and a few selected examples of his research will be presented.